Other studies reported that the activation of protein kinase C and extracellular signal-related kinase 1/2 are necessary for GnRH-induced ovarian cancer cell death [36], but it is still uncertain whether these early signaling events are mediated by the cognate receptor or nonspecifically activated by the antagonists. The gene discussed is MAPK3; the disease is ovarian carcinoma.